1
Thomas J Borody: Treatment of non-inflammatory and non-infectious bowel disorders. James Ray & Associates, May 21, 1996: US05519014 (63 worldwide citation)

A medicine for treating non-inflammatory and non-infectious bowel disorders, such as irritable bowel syndrome, constipation, non-ulcer dyspepsia, gastro-oesophageal reflux with or without oesophagitis, and diverticular disease, comprising a salicylic acid derivative, such as any one of sulfasalazine ...


2
Borody Thomas Julius: Treatment of non-inflammatory and non-infectious bowel disorders.. Borody Thomas J, August 11, 1993: EP0554291-A1 (13 worldwide citation)

A medicine for treating non-inflammatory and non-infectious bowel disorders, such as irritable bowel syndrome, constipation, non-ulcer dyspepsia, gastro-oesophageal reflux with or without oesophagitis, and diverticular disease, comprising a salicylic acid derivative, such as any one of sulfasalazine ...


3
Borody Thomas Julius: Traitement des troubles intestinaux non inflammatoires et non infectieux, Treatment of non-inflammatory and non-infectious bowel disorders. Borody Thomas Julius, Gastro Services, SMART & BIGGAR, April 30, 1992: CA2090220 (6 worldwide citation)

A medicine for treating non-inflammatory and non-infectious bowel disorders, such as irritable bowel syndrome, constipa-tion, non-ulcer dyspepsia, gastro-oesophageal reflux with or without oesophagitis, and diverticular disease, comprising a salicylic acid derivative, such as any one of sulfasalazin ...


4
Borody Thomas Julius: Treatment of non-inflammatory and non-infectious bowel disorders. Borody Thomas Julius, CARTER SMITH Qantas House 2 Railway Parade Camberwell VIC 3124, April 30, 1992: WO/1992/006690

A medicine for treating non-inflammatory and non-infectious bowel disorders, such as irritable bowel syndrome, constipation, non-ulcer dyspepsia, gastro-oesophageal reflux with or without oesophagitis, and diverticular disease, comprising a salicylic acid derivative, such as any one of sulfasalazine ...


5
METHODS OF DIAGNOSING AND TREATING SMALL INTESTINAL BACTERIAL OVERGROWTH (SIBO) AND SIBO-RELATED CONDITIONS. Cedars Sinai Medical Center, April 6, 2017: US20170095543-A1

Disclosed is a method of treating small intestinal bacterial overgrowth (SIBO) or a SIBO-caused condition in a human subject. SIBO-caused conditions include irritable bowel syndrome, fibromyalgia, chronic pelvic pain syndrome, chronic fatigue syndrome, depression, impaired mentation, impaired memory ...



Click the thumbnails below to visualize the patent trend.